# BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis

> **NCT00736840** · PHASE3 · COMPLETED · sponsor: **Meridian Bioscience, Inc.** · enrollment: 414 (actual)

## Conditions studied

- Chronic Liver Disease

## Interventions

- **DEVICE:** c13 methacetin solution with breath analyzer

## Key facts

- **NCT ID:** NCT00736840
- **Lead sponsor:** Meridian Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 414 (ACTUAL)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736840, "BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00736840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*